Quantcast

Latest Novo Nordisk Stories

2014-08-14 08:28:43

DUBLIN, Aug. 14, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global and Chinese Diabetes Drugs Industry Report 2014" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The Global and Chinese Diabetes Drugs Industry Report 2014 is a professional and in-depth study on the current state of the global diabetes drugs industry with a focus on the Chinese situation. The report provides a basic overview of the industry including...

2014-08-06 12:28:26

Microneedle Patches and Subcutaneous Implants Offer Significant Revenue Potential, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 6, 2014 /PRNewswire/ -- Decision Resources Group finds that the United States drug delivery device market will grow at a strong rate to reach a value of over $4.5 billion by 2022 (including device costs only). The future of the drug delivery device market is highly dependent on the pharma industry. Because certain types of drugs are...

2014-08-06 08:31:42

PORTLAND, Oregon, August 6, 2014 /PRNewswire/ -- A new report by Allied Market Research entitled, "Nonalcoholic Steatohepatitis Market (Pipeline analysis, drug class and Geography) Global Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2013 - 2020", indicates that the global nonalcoholic steatohepatitis (NASH) market would reach $1.6 billion by 2020 registering CAGR of 25.6% from 2014 to 2020. The high prevalence of Type II diabetes and obesity, which lead...

2014-07-31 08:33:54

ALBANY, New York, July 31, 2014 /PRNewswire/ -- MarketResearchreports.biz presents this most up-to-date research on Global and China Insulin Market [http://www.marketresearchreports.biz/analysis/137594 ] (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, And Modern and Human Insulin) - Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume), 2013 - 2019: Market Size, Trends, and Forecasts Research Report. Diabetes, growing at...

2014-07-28 12:27:31

DUBLIN, July 28, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Rheumatoid Arthritis Drugs Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 RA is a chronic disease that leads to inflammation and pain in the human body's joints such as wrists, fingers, knees, feet, and ankles. In addition, it causes inflammation of the tissues that surround the joints and in other organs. The symptoms of RA begin slowly,...

2014-07-25 12:24:51

ALBANY, New York, July 25, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, Modern and Human Insulin) - Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume), 2013 - 2019", the global insulin market was valued at USD 19.99 billion in 2012 and is expected to grow at a CAGR of 6.1% from 2013 to 2019 to...

2014-07-23 23:23:16

The human insulin market is segmented based on types of insulin, and branded drugs available in the market. http://www.marketsandmarkets.com/Market-Reports/human-insulin-market-229295783.html. (PRWEB) July 22, 2014 The “Human Insulin Market by Product Type [Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed)], by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to 2019” provides a...

2014-07-23 12:32:02

DALLAS, July 23, 2014 /PRNewswire/ -- Expiring biologic human insulin market drugs' patents are set to create new opportunities for biosimilar drugs, which is estimated to grow at a CAGR of 35% from 2014-2019. This, as per the report titled "Human Insulin Market by Product Type (Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed), by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) -...

2014-07-18 16:23:18

DUBLIN, July 18, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3txjqf/global_type_1) has announced the addition of the "Global Type 1 Diabetes Market 2014-2018" [http://www.researchandmarkets.com/research/3txjqf/global_type_1 ] report to their offering. Type 1 diabetes is an autoimmune disorder characterized by high blood glucose levels. In this condition, the immune system is activated against self-insulin producing cells. This,...

2014-07-16 20:22:30

LONDON, July 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Insulin Market Outlook 2018 https://www.reportbuyer.com/product/2080565/Global-Insulin-Market-Outlook-2018.html About 381 Million people suffered from diabetes in 2013 globally, which is likely to reach 591 Million by 2035. The growing number of diabetes patients at such a high pace significantly increases the demand for insulin products. The discovery of Insulin therapy has...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related